Insiders Buying Nuvectis Pharma And 2 Other Stocks
Portfolio Pulse from Lisa Levin
Insiders at Nuvectis Pharma, Fastenal Company, and Lockheed Martin have recently made notable purchases of their companies' stocks. This could indicate their confidence in the companies' prospects or that they view the stocks as a bargain. Nuvectis Pharma recently announced the FDA clearance of NXP900 IND. Fastenal reported Q2 sales growth of 5.9% Y/Y to $1.88 billion, slightly missing the consensus of $1.89 billion. Lockheed Martin reported Q2 FY23 net sales growth of 8.1% Y/Y to $16.69 billion, above the consensus of $15.91 billion.
July 20, 2023 | 10:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Insider at Fastenal Company purchased 500 shares at an average price of $57.53. The company reported Q2 sales growth of 5.9% Y/Y to $1.88 billion, slightly missing the consensus of $1.89 billion.
Insider purchases often indicate confidence in a company's prospects. Despite slightly missing Q2 sales consensus, the company still reported growth, which could be seen as a positive sign.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Insider at Lockheed Martin purchased 548 shares at an average price of $457.07. The company reported Q2 FY23 net sales growth of 8.1% Y/Y to $16.69 billion, above the consensus of $15.91 billion.
Insider purchases often indicate confidence in a company's prospects. The company's above consensus Q2 FY23 net sales growth could be a positive catalyst for the company.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Insider at Nuvectis Pharma purchased 9,149 shares at an average price of $14.84. The company recently announced the FDA clearance of NXP900 IND.
Insider purchases often indicate confidence in a company's prospects. The recent FDA clearance of NXP900 IND could be a positive catalyst for the company.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100